Dracocephalum: Novel anticancer plant acting on liver cancer cell mitochondria

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Talari, Mojtaba ^a   Seydi, Enayatollah ^a   Salimi, Ahmad ^a   Mohsenifar, Zhaleh ^a   Kamalinejad, Mohammad ^a   Pourahmad, Jalal ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; APIGENIN; ASPARTATE AMINOTRANSFERASE; CALYCOPERIN; CIRSIMARITIN; CYTOCHROME C; CYTOCHROME C OXIDASE; ISOKAEMPFEROIDE; LUTEOLIN; N (2 FLUORENYL)ACETAMIDE; NARINGENIN; PENDULETIN; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; SUCCINATE DEHYDROGENASE; UNCLASSIFIED DRUG; XANTHOMICROL; ANTIOXIDANT; PLANT EXTRACT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALPHA FETOPROTEIN BLOOD LEVEL; ANIMAL CELL; APOPTOSIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRACOCEPHALUM KOTSCHYI; ENZYME ACTIVITY; FLOW CYTOMETRY; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; MALE; MEDICINAL PLANT; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; MITOCHONDRION SWELLING; NONHUMAN; PROTEIN SECRETION; RAT; ANIMAL; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE PERMEABILITY; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; HUMAN; LAMIACEAE; LIPID PEROXIDATION; LIVER NEOPLASMS; METABOLISM; PATHOLOGY;

ANIMALS; ANTIOXIDANTS; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE PERMEABILITY; HEPATOCYTES; HUMANS; LAMIACEAE; LIPID PEROXIDATION; LIVER NEOPLASMS; MALE; MITOCHONDRIA; MITOCHONDRIAL MEMBRANES; PLANT EXTRACTS; RATS; REACTIVE OXYGEN SPECIES;

EID: 84929056187     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/892170     Document Type: Article

References (32)

1. V. Kumar, N. Fausto, and A. Abbas, Eds. , Robbins & Cotran Pathologic Basis of Disease, Elsevier Saunders, 7th edition, 2003.
2. T. H. Chen, C. Chen, M. Yen et al. , "Ultrasound screening and risk factors for death from hepatocellular carcinoma in a high risk group in Taiwan, " International Journal of Cancer, vol. 98, no. 2, pp. 257-261, 2002.
3. R. F. Veĺazquez, M. Rodŕguez, C. A. Navascúes et al. , "Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis, " Hepatology, vol. 37, no. 3, pp. 520-527, 2003.
4. E. Farber, "The step-by-step development of epithelial cancer: fromphenotype to genotype, " Advances in Cancer Research, vol. 70, pp. 21-48, 1998.
5. S. EbrahimSajjadi, A. Movahedian Atar, and A. Yektaian, "Antihyperlipidemic effect of hydroalcoholic extract, and polyphenolic fraction from Dracocephalum kotschyi Boiss, " Pharmaceutica Acta Helvetiae, vol. 73, no. 3, pp. 167-170, 1998.
6. Z. Amirghofran, M. Azadbakht, and M. H. Karimi, "Evaluation of the immunomodulatory effects of five herbal plants, " Journal of Ethnopharmacology, vol. 72, no. 1-2, pp. 167-172, 2000.
7. M. G. von Brandenstein, A. N. Abety, R. Depping et al. , "A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells, " Biochimica et Biophysica Acta, vol. 1783, no. 9, pp. 1613-1622, 2008.
8. D. E. Clapham, "Calcium Signaling, " Cell, vol. 131, no. 6, pp. 1047-1058, 2007.
9. M. R. Green, "Targeting Targeted Therapy, " The New England Journal of Medicine, vol. 350, no. 21, pp. 2191-2193, 2004.
10. P. L. Toogood, "Mitochondrial drugs, " Current Opinion in Chemical Biology, vol. 12, pp. 457-463, 2008.
11. J. S. Modica-Napolitano and K. K. Singh, "Mitochondrial dysfunction in cancer, " Mitochondrion, vol. 4, no. 5-6, pp. 755-762, 2004.
12. V. Máximo and M. Sobrinho-Simoes, "Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance, " Virchows Archiv, vol. 437, no. 2, pp. 107-115, 2000.
13. G. Moghaddam, S. A. Ebrahimi, N. Rahbar-Roshandel, and A. Foroumadi, "Antiproliferative activity of flavonoids: influence of the sequential methoxylation state of the flavonoid structure, " Phytotherapy Research, vol. 26, no. 7, pp. 1023-1028, 2012.
14. M. M. E. Taha, A. B. Abdul, R. Abdullah, T. A. T. Ibrahim, S. I. Abdelwahab, and S. Mohan, "Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorenepromoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet), " Chemico-Biological Interactions, vol. 186, no. 3, pp. 295-305, 2010.
15. J. Pourahmad and P. J. OBrien, "A comparison of hepatocyte cytotoxicmechanisms for Cu2+ and Cd2+, " Toxicology, vol. 143, no. 3, pp. 263-273, 2000.
16. P. O. Seglen, "Preparation of isolated rat liver cells, " in Methods in Cell Biology, D. M. Prescott, Ed. , vol. 13, pp. 29-83, 1976.
17. S. Barogi, A. Baracca, G. P. Castelli et al. , "Lack of major changes in ATPase activity in mitochondria from liver, heart, and skeletal muscle of rats upon ageing, " Mechanisms of Ageing and Development, vol. 84, no. 2, pp. 139-150, 1995.
18. M. M. Bradford, "A rapid and sensitive method for the quantitation ofmicrogramquantities of protein utilizing the principle of protein dye binding, " Analytical Biochemistry, vol. 72, no. 1-2, pp. 248-254, 1976.
19. F. Shaki, M. Hosseini, M. Ghazi-Khansari, and J. Pourahmad, "Toxicity of depleted uranium on isolated rat kidney mitochondria, " Biochimica et BiophysicaActa-General Subjects, vol. 1820, no. 12, pp. 1940-1950, 2012.
20. Y. Zhao, L. Ye, H. Liu et al. , "Vanadium compounds induced mitochondria permeability transition pore (PTP) opening related to oxidative stress, " Journal of Inorganic Biochemistry, vol. 104, no. 4, pp. 371-378, 2010.
21. A. Baracca, G. Sgarbi, G. Solaini, and G. Lenaz, "Rhodamine 123 as a probe ofmitochondrialmembrane potential: Evaluation of proton flux through F0 during ATP synthesis, " Biochimica et Biophysica Acta, vol. 1606, no. 1-3, pp. 137-146, 2003.
22. L. Reddy, B. Odhav, and K. D. Bhoola, "Natural products for cancer prevention: a global perspective, " Pharmacology and Therapeutics, vol. 99, no. 1, pp. 1-13, 2003.
23. Y.-J. Surh, "Cancer chemoprevention with dietary phytochemicals, " Nature Reviews Cancer, vol. 3, no. 10, pp. 768-780, 2003.
24. J. M. Luk, X.-L. Wang, P. Liu et al. , "Traditional Chinese herbal medicines for treatment of liver fibrosis and cancer: from laboratory discovery to clinical evaluation, " Liver International, vol. 27, no. 7, pp. 879-890, 2007.
25. Y. Cai, Q. Luo, M. Sun, and H. Corke, "Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer, " Life Sciences, vol. 74, no. 17, pp. 2157-2184, 2004.
26. T. Efferth, P. C. H. Li, V. S. B. Konkimalla, and B. Kaina, "From traditional Chinesemedicine to rational cancer therapy, " Trends in Molecular Medicine, vol. 13, no. 8, pp. 353-361, 2007.
27. N. R. Monks, S. A. L. Bordignon, A. Ferraz et al. , "Anti-tumour screening of Brazilian plants, " Pharmaceutical Biology, vol. 40, no. 8, pp. 603-616, 2002.
28. Q. M. Bo, Z. Y. Wu, Q. S. Shun, X. S. Bao, and Z. S. Mao, A Selection of the Illustrated Chinese Anti-Cancer Herbal Medicines, Shanghai Science and Technology Literature Press, Shanghai, China, 2002.
29. I. A. Barbosa, N. G. Machado, A. J. Skildum, P. M. Scott, and P. J. Oliveira, "Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies, " Biochimica et Biophysica Acta-Reviews on Cancer, vol. 1826, no. 1, pp. 238-254, 2012.
30. D. M. Stocco and J. C. Hutson, "Characteristics of mitochondria isolated by rate zonal centrifugation from normal liver and novikoff hepatomas, " Cancer Research, vol. 40, no. 5, pp. 1486-1492, 1980.
31. K. Debatin, D. Poncet, and G. Kroemer, "Chemotherapy: targeting the mitochondrial cell death pathway, " Oncogene, vol. 21, no. 57, pp. 8786-8803, 2002.
32. D. D. Newmeyer and S. Ferguson-Miller, "Mitochondria: releasing power for life and unleashing the machineries of death, " Cell, vol. 112, no. 4, pp. 481-490, 2003.